Skip to main content

Sheffield Pain Relief

NDC 11527-062 · Sheffield Pharmaceuticals LLC

Generic nameBENZOCAINE

Dosage formGEL

RouteORAL

Active ingredient(s)BENZOCAINE

Strength200 mg/g

Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Standardized Chemical Allergen [EPC]

Marketing categoryOTC MONOGRAPH DRUG

Packages

11527-062-47 — 1 TUBE in 1 CARTON (11527-062-47) / 9.35 g in 1 TUBE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

10733-171 — Benzocaine, 10733-173 — Benzocaine, 10733-174 — Benzocaine, 10733-175 — Benzocaine, 10733-176 — Benzocaine, 10733-415 — salicylic acid and benzocaine, 10742-8902 — benzocaine, 10742-8915 — benzocaine, 11509-4402 — Benzocaine and Resorcinol, 11509-5103 — Benzocaine and Resorcinol, 11822-0316 — Benzocaine, 11822-0345 — Benzocaine, 11822-0613 — Benzocaine, 11822-0614 — Benzocaine, 11822-0615 — Benzocaine, 11822-1343 — Benzocaine 20%, Menthol 0.5%, 11822-1616 — Benzocaine, 11822-5340 — Benzocaine, 11822-6170 — Benzocaine, 11822-6300 — Benzocaine, +563 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels